XOMA completes acquisition of HilleVax for $1.95 per share plus CVR

XOMA Royalty Corp

XOMA acquired HilleVax via tender offer and merger; offer price of $1.95 cash plus one CVR per share.
Approximately 77.48% of HilleVax shares were tendered (39,214,689 shares) and accepted.
Merger closed September 17, 2025; HilleVax is now a wholly owned subsidiary of XOMA.
CVR represents right to receive potential cash payments under CVR Agreement dated September 17, 2025.
Financial statements of HilleVax will be filed in an amendment to this Form 8-K.

item 2.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.